Drug Type Small molecule drug |
Synonyms JS 101, JS-101 |
Target |
Mechanism CDK inhibitors(Cyclin-dependent kinase (CDK) family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13N3 |
InChIKeyCLPFFLWZZBQMAO-UHFFFAOYSA-N |
CAS Registry102676-47-1 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | CN | 23 Jan 2024 | |
Breast Cancer | Phase 2 | CN | 22 Oct 2018 | |
Lymphoma | IND Application | CN | 22 Aug 2018 |